-
October 15, 2012
The Nasdaq is up 0.3%, the S&P 500 has risen 0.3% and the Dow has climbed 0.3%, marking a bad morning for the ...
-
October 12, 2012
Isis Pharmaceuticals, Inc. (ISIS) recently announced that it has invested $3 million in biopharma company Regulus ...
-
October 05, 2012
Regulus Therapeutics Inc., founded by Alnylam Pharmaceuticals (ALNY) and Isis Pharmaceuticals, Inc. (ISIS), recently ...
-
October 03, 2012
The Nasdaq is up 0.7%, the S&P 500 has climbed 0.5% and the Dow has moved up 0.3%, marking a bad morning for the ...
-
October 02, 2012
So far today, the Nasdaq has climbed 0.4%, the S&P 500 is up 0.1% and the Dow is trading down 0.2%. The healthcare ...
-
September 21, 2012
This morning, the Nasdaq has moved little, the S&P 500 has decreased 0.3% and the Dow has been relatively flat. The ...
-
September 21, 2012
Currently, the Nasdaq has moved little, the S&P 500 is trading down 0.3% and the Dow has remained steady. The ...
-
September 04, 2012
The market is currently down, with the Nasdaq slipping 0.8%, the S&P 500 down 0.6% and the Dow declining 0.8%. The ...
-
August 22, 2012
Regulus Therapeutics Inc., founded by Alnylam Pharmaceuticals (ALNY) and Isis Pharmaceuticals, Inc. (ISIS), recently ...
-
August 16, 2012
Regulus Therapeutics Inc. and Biogen Idec (BIIB) recently entered into a deal to identify microRNAs ...
-
August 09, 2012
Isis Pharmaceuticals Inc. (ISIS) reported a net loss of 1 cent per share in the second quarter of 2012, well below ...
-
August 06, 2012
The market is currently up, with the Nasdaq climbing 1%, the S&P 500 rising 0.5% and the Dow up 0.6%. The healthcare ...
-
July 19, 2012
It's been a good morning for the market. The Nasdaq is up 1.1%; the S&P 500 has climbed 0.3%; and the Dow has moved ...
-
July 12, 2012
The market is currently down, with the Nasdaq decreasing 1.3%, the S&P 500 falling 0.8% and the Dow declining 0.5%. ...
-
July 11, 2012
We recently reiterated our Neutral recommendation on Isis Pharmaceuticals (ISIS), which carries a Zacks #3 Rank ...
-
July 02, 2012
Isis Pharmaceuticals, Inc. (ISIS) and Biogen Idec (BIIB) have teamed up again. This time round the companies are ...
-
September 02, 2011
XOMA changes management again, but should anybody care?
-
April 19, 2011
Strong clinical data sends Amarin's stock soaring.
-
February 18, 2011
Though Sanofi finally got its way in acquiring Genzyme, time will determine if stockholders will truly benefit.
-
September 01, 2010
Sanofi has decided to make its intentions public and ratchet up the pressure on GENZ management.
